Sagimet Biosciences Inc. Series A Common Stock (SGMT) earnings · $403.2M cap
These earnings events as JSON? API free 100/daySagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
This SGMT earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported SGMT revenue for 2023-09-30 was $2.0M. Net income was -$6.4M. Revenue was up 0.0% from 2023-07-31 to 2023-09-30. SGMT currently screens at market cap $403.2M.
When the next SGMT 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 0.0% from 2023-07-31 to 2023-09-30. An earnings headline that ignores that move is noise.
Not investment advice. Full SGMT research stays on the stock page; the tape stays on the quote page.
SGMT earnings FAQ
What are SGMT's latest revenue and net income?
Latest cached Sagimet Biosciences Inc. Series A Common Stock (SGMT) revenue for Sep 30, 2023 was $2.0M. Net income was -$6.4M. Statements: https://lician.com/financials/sgmt
What is SGMT's latest diluted EPS?
Latest cached Sagimet Biosciences Inc. Series A Common Stock (SGMT) diluted EPS for Sep 30, 2023 was -$0.35.
What period does the latest SGMT earnings print cover?
The latest cached Sagimet Biosciences Inc. Series A Common Stock (SGMT) earnings print covers Sep 30, 2023. The prior cached period on this page is Jul 31, 2023.
How did SGMT revenue change from the prior cached period?
Cached Sagimet Biosciences Inc. Series A Common Stock (SGMT) revenue was unchanged from $2.0M (Jul 31, 2023) to $2.0M (Sep 30, 2023). Statements: https://lician.com/financials/sgmt
Where are SGMT earnings listed?
Cached earnings facts for Sagimet Biosciences Inc. Series A Common Stock (SGMT) are listed at https://lician.com/earnings/sgmt. Statements: https://lician.com/financials/sgmt
Not investment advice.